# Systemic Steroids for Peripheral Nerve Blocks

> **NCT02464176** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 115 (actual)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Bupivacaine
- **DRUG:** Epinephrine
- **PROCEDURE:** Lumbar Plexus Nerve Block
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02464176
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464176, "Systemic Steroids for Peripheral Nerve Blocks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02464176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*